Kempner Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-106,601
Closed -$3.08M 52
2024
Q3
$3.08M Hold
106,601
1.58% 30
2024
Q2
$2.98M Buy
106,601
+18,700
+21% +$515K 1.58% 29
2024
Q1
$2.44M Buy
+87,901
New +$2.44M 1.32% 33
2021
Q3
Sell
-32,950
Closed -$1.29M 55
2021
Q2
$1.29M Hold
32,950
0.73% 41
2021
Q1
$1.19M Hold
32,950
0.69% 38
2020
Q4
$1.21M Sell
32,950
-33,225
-50% -$1.22M 0.8% 36
2020
Q3
$2.3M Hold
66,175
1.84% 26
2020
Q2
$2.05M Sell
66,175
-154
-0.2% -$5.23K 1.61% 30
2020
Q1
$2.05M Buy
66,329
+38,502
+138% +$1.31M 1.79% 27
2019
Q4
$1.03M Sell
27,827
-53
-0.2% -$1.89K 0.67% 40
2019
Q3
$950K Hold
27,880
0.64% 38
2019
Q2
$1.15M Hold
27,880
0.75% 38
2019
Q1
$1.12M Sell
27,880
-4
-0% -$160 0.74% 38
2018
Q4
$1.16M Hold
27,884
0.79% 39
2018
Q3
$1.17M Sell
27,884
-32,175
-54% -$1.24M 0.75% 38
2018
Q2
$2.07M Sell
60,059
-22
-0% -$752 1.36% 29
2018
Q1
$2.02M Buy
60,081
+231
+0.4% +$7.94K 1.38% 29
2017
Q4
$2.06M Sell
59,850
-568
-0.9% -$19.4K 1.28% 27
2017
Q3
$2.05M Buy
60,418
+1,438
+2% +$46.2K 1.35% 24
2017
Q2
$1.88M Buy
+58,980
New +$1.86M 1.24% 26

Other funds holding PFE

Kempner Capital Management's PFE Position: Q4 2024 in Review

Kempner Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 106,601 shares — an estimated $3.08M sold.

Kempner Capital Management first reported a position in PFE in Q2 2017 and held it in 20 quarters. The position peaked at $3.08M in Q3 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Kempner Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Kempner Capital Management sold 106,601 Pfizer shares in Q4 2024, an estimated $3.08M.
  • Kempner Capital Management first reported a position in Pfizer in Q2 2017 and held it in 20 quarters.
  • Kempner Capital Management's Pfizer position peaked at $3.08M in Q3 2024.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Kempner Capital Management's 13F filing for Q4 2024, filed 23 Jan 2025.